𝔖 Bobbio Scriptorium

✦ LIBER ✦

58PD VATS LOBECTOMY AFTER INDUCTION THERAPY FOR LUNG CANCER: A SAFE AND EFFECTIVE METHOD

✍ Scribed by Wu, Y.C.; Chao, Y.K.

Book ID: 122332012
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 43 KB
Volume: 80
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(13)70279-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-897 Thoracoscopic lobectomy: A safe an

P-897 Thoracoscopic lobectomy: A safe and effective approach for patients with down stage lung cancer after induction therapy

✍ Lu, M.; Liu, H.; Hsieh, M.; Wu, Y.; Liu, Y. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Thoracoscopic Lobectomy: A Safe and Effe

Thoracoscopic Lobectomy: A Safe and Effective Strategy for Patients Receiving Induction Therapy for Non-Small Cell Lung Cancer

✍ Rebecca P. Petersen; DuyKhanh Pham; Eric M. Toloza; William R. Burfeind; David H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Thoracoscopic lobectomy: a safe and effe

Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer

✍ Larkin J Daniels; Stafford S Balderson; Mark W Onaitis; Thomas A D’Amico 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 62 KB

High-Dose Hypofractionated Proton Beam R

High-Dose Hypofractionated Proton Beam Radiation Therapy Is Safe and Effective for Central and Peripheral Early-Stage Non-Small Cell Lung Cancer: Results of a 12-Year Experience at Loma Linda University Medical Center

✍ Bush, David A.; Cheek, Gregory; Zaheer, Salman; Wallen, Jason; Mirshahidi, Hamid 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB